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This is one of a series of BMJ 
summaries of new guidelines 
based on the best available 
evidence; they highlight important 
recommendations for clinical 
practice, especially where 
uncertainty or controversy exists.
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It is generally believed that early diagnosis of can-
cer reduces mortality and morbidity. The National 
Institute for Health and Care Excellence (NICE) has 
updated its 2005 guidance on the recognition and 
referral from primary care of people with suspected 
cancer.1  This summary of the full guidance is in two 
parts: part 1 on recommendations for children (up 
to 15 years old) and young adults (16-24 years), and 
part 2 on those for adults. Separate recommenda-
tions have been made for adults and for children and 
young people to reflect that there are different refer-
ral pathways. However, in practice young people 
(aged 16–24) may be referred using either an adult or 
children’s pathway depending on their age and local 
arrangements. The full guidance will be available on 
thebmj.com.
Key changes in the updated guidance are:
•   Reliance on new evidence derived from primary, 
rather than secondary, care
•   Explicit use of a threshold risk of cancer to underpin 
recommendations for urgent investigation—the first 
cancer guidance to do so.2  
HOW PATIENTS WERE INVOLVED
Committee members involved in this guideline 
update included lay members who contributed 
to the formulation of the recommendations 
summarised here.
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Recommendations
The figure lists symptoms of possible child-
hood c ancer, the cancers that may underlie these 
sy mptoms, and the recommended investigations 
or referral. 
1) Turquoise—primary care investigation
2) Purple—referral to be seen within two weeks
3) Orange—referral to be seen within 48 hours
4) Pink—immediate referral
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THE BOTTOM LINE
• Nearly all possible 
childhood cancers require 
referral for investigation, as 
primary care testing is only 
of use in sarcomas (very 
urgent ultrasound or x ray) 
and leukaemias (full blood 
counts)
• Abnormal primary care 
tests for cancer all warrant 
urgent referral
This guidance:
•   Assumes that patients will have had a full history, 
clinical examination, and appropriate initial blood 
tests
•   Recommends urgent investigation in adults 
with a 3% or higher cancer risk, but uses a lower 
threshold for children and young people and when 
primary care testing is available 
•   Relies on evidence mainly from moderate quality 
observational studies. The evidence base for 
each recommendation is incorporated in the full 
guidance, but has been omitted here for ease of 
reading.
•   Will increase the number of investigations or 
referrals in some cancer sites; the use of direct 
access testing should reduce the costs of this, but 
will require organisational change
•   Asks clinicians to continue to trust their clinical 
experience where there are particular reasons that 
the guidance isn’t relevant to a patient’s specific 
presentation.
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 Ж Read more NICE guidelines in 
The BMJ at http://www.bmj.com/
specialties/guideline-summaries
